packageTildrakizumab
tildrakizumab
Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).
Information
Tildrakizumab, a monoclonal antibody that blocks an interleukin signal, is used to treat psoriasis. It is an approved medicine and is authorised in the European Union for this condition.
Summary written by glm-5.3-flash from Wikidata Q15708331 and the WHO ATC classification and the EMA medicines list; not checked by a person.
| name: | tildrakizumab |
| ATC codes: | L04AC17 |
| DrugBank: | DB14004 |
| Wikidata: | Q15708331 |
| molar mass: | 144400 g/mol (Drugs.Common 25.09, not verified) |
Parameters
| Type | Name | Default | Description |
|---|---|---|---|
| String | name (from PartialSubstance) | "" | INN / common name |
| String[:] | atcCodes (from PartialSubstance) | fill("", 0) | all WHO ATC codes of the drug |
| String | drugbankId (from PartialSubstance) | "" | e.g. DB00758 |
| String | pubchemCid (from PartialSubstance) | "" | PubChem compound id |
| String | chebiId (from PartialSubstance) | "" | ChEBI id (number) |
| String | wikidataId (from PartialSubstance) | "" | e.g. Q410238 |
| String | formula (from PartialSubstance) | "" | molecular formula |
| Modelica.Units.SI.MolarMass | M (from PartialSubstance) | 0 | molar mass; 0 = unknown |
| Real | logP (from PartialSubstance) | Modelica.Constants.inf | octanol-water partition coefficient (log10); inf = unknown |